TrialCM4620 Injectable Emulsion Versus Supportive Care in Patients With Acute Pancreatitis and SIRS
Trial details
- Registry ID
- NCT03401190
- Phase
- Phase 2
Drug research
CM4620 Injectable Emulsion (High Dose)
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as CM4620-IE (High Dose)
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| CM4620 Injectable Emulsion Versus Supportive Care in Patients With Acute Pancreatitis and SIRSNCT03401190 | CALC | Phase 2 | Completed | 2019-02-14Actual |
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |